# Pro-life group says Trump admin didn’t give key abortion drug commitments before Overton FDA nomination pulled

- URL: https://talkfuse.com/story/pro-life-group-says-trump-admin-didnt-give-key-abortion-drug-commitments-before-overton-fda-nomination-pulled/
- Published: 2026-11-20T05:32:52+00:00
- Updated: 2026-11-20T06:23:46+00:00
- Original publisher: Fox News (publisher lean: Right)
- Original article: https://www.foxnews.com/politics/pro-life-group-says-trump-admin-didnt-give-key-abortion-drug-commitments-overton-fda-nomination-pulled
- Topics: Americas, Health, Medicine, World

## Key points

- Anti-abortion group sought policy commitments before Overton’s confirmation.
- The White House withdrew her nomination before a committee vote.
- FDA review results are expected in December 2026.

## Summary

A leading anti-abortion group said it opposed advancing Heidi Overton’s nomination to lead the US Food and Drug Administration unless the Trump administration made commitments on abortion drug policy. The White House withdrew her nomination before a Senate committee vote, saying she lacked sufficient support, leaving the agency’s leadership in acting hands.

The group wants the next nominee to end mail-order access to abortion drugs and ensure a new FDA review of mifepristone uses more robust data, transparent methods and outside experts. The Biden-era policy removed the requirement for in-person dispensing, while the FDA says its safety review is under way, with results expected in December 2026 and a final report by March 2027. Overton, a physician and White House adviser, was nominated in August to succeed Marty Makary, who resigned in May.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
